Innocan Pharma Corp. buy EarningsForward40
Start price
22.01.25
/
50%
€0.11
Target price
22.02.25
-
Performance (%)
36.28%
End price
23.02.25
€0.15
Summary
This prediction ended on 23.02.25 with a price of €0.15. With a performance of 36.28% the BUY prediction by EarningsForward40 was a big success. EarningsForward40 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Innocan Pharma Corp. | - | - | - |
| iShares Core DAX® | -6,02 % | -4,60 % | 1,27 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % | 14,57 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % | 28,11 % |
| iShares S&P 500 | -0,26 % | -0,84 % | 10,20 % |
Comments by EarningsForward40 for this prediction
In the thread Trading Innocan Pharma Corp.
Die von EarningsForward40 gewählte maximale Laufzeit wurde überschritten